Advertisement
Sunday, Nov 28, 2021
Outlook.com
Outlook.com

Sensex, Nifty Extend Record Run On Vaccine Booster

After opening strong, the stock indices gave up gains due to profit booking by investors. However, positive trends in the European stocks helped the indices rebound and end at record levels.

Sensex, Nifty Extend Record Run On Vaccine Booster
Representational Image
Sensex, Nifty Extend Record Run On Vaccine Booster
outlookindia.com
2020-12-30T16:42:06+05:30

Benchmark indices Sensex and Nifty raced to fresh record highs on Wednesday as gains in financials, auto and IT shares helped markets extend their winning run for the sixth straight session.

After a volatile session, the 30-share BSE Sensex closed up by 133.14 points or 0.28 per cent at a record high of 47,746.22. The barometer scaled its all-time intra-day high of 47,807.85.
The broad-based NSE Nifty rose by 49.35 points or 0.35 per cent to finish at its lifetime high of 13,981.95. It touched all-time peak of 13,997 in intra-day trade.

Among major Sensex movers, Ultratech Cement rose over 4 per cent, Bajaj Finance by 2.63 per cent and Maruti by 2 per cent. Mahindra and Mahindra, Tech Mahindra, HUL, Kotak Bank, HDFC Bank, Reliance Industries and Asian Paints also finished in the green.

After opening strong, the stock indices gave up gains due to profit booking by investors. However, positive trends in the European stocks helped the indices rebound and end at record levels.

European stocks advanced on Wednesday as the UK approved the Covid-19 vaccine developed by AstraZeneca and Oxford University. Britain has authorized use of a second Covid-19 vaccine, becoming the first country to greenlight an easy-to-handle shot that its developers hope will become the "vaccine for the world".

Asian shares were mixed after a lacklustre day on Wall Street. Benchmarks fell in Tokyo and Sydney but rallied in Hong Kong, Seoul and Shanghai.

Japan's Nikkei 225 fell 0.5 per cent, a day after it surged more than 2 per cent to its highest level in more than 30 years. In Australia, the S&P/ASX 200 lost 0.3 per cent.

On the other hand, Hong Kong's Hang Seng surged 1.6 per cent, the Shanghai Composite index advanced 1 per cent while South Korea's Kospi jumped 1.9 per cent.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Omicron: New Strain Of Coronavirus Escalates Need For Global Vaccine Sharing

Omicron: New Strain Of Coronavirus Escalates Need For Global Vaccine Sharing

'Despite the repeated warnings of health leaders, our failure to put vaccines into the arms of people in the developing world is now coming back to haunt us', wrote former British PM Gordon Brown.

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Though the health experts and scientists in India have advised caution yet they feel that the current immune profile of the majority of the population in India makes them less vulnerable to Omicron as compared to any other country in the world.

1st Test: India Need 9 Wickets To Win Vs NZ On Final Day

1st Test: India Need 9 Wickets To Win Vs NZ On Final Day

From 51/5, half-centuries by Shreyas Iyer and Wriddhiman Saha helped India declare at 234/7. New Zealand (4/1) need 280 runs to win on Day 5 on Monday.

What Is Omicron: All You Need To Know About The New Coronavirus Strain

What Is Omicron: All You Need To Know About The New Coronavirus Strain

After the detrimental Delta variant which took the world by storm in the second wave of Covid-19, WHO recently declared ‘Omicron’ as the latest ‘variant of concern’ (VOC).

Advertisement